M Kawashima, M Murakami, T Saito, I Oyama, M Tauchi, K Oikawa, M Sekine, T Sekine, N Ozawa, Y.Saito, H Yamaji, Y Yagiuchi, A Kumagai and K Otani.

Lessons from and perspectives for healthcare student volunteer activities after the Fukushima disaster.

Radioprotection 2020, 55(4), 271–276.

Mitani Y, Kanai M, Kou T, Kataoka S, Doi K, Matsubara J, Ohashi S, Matsumoto S, Muto M.

Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report.

BMC Cancer. 2020 Dec 2;20(1):1177.

Iwai T, Yoshimura M, Ashida R, Goto Y, Kishi T, Itasaka S, Shibuya K, Kanai M, Masui T, Fukuda A, Isoda H, Hiraoka M, Mizowaki T.

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma.

Radiat Oncol. 2020 Nov 13;15(1):264.

Naomi Kakushima, Naohiro Yoshida, Hisashi Doyama, Tomonori Yano, Takahiro Horimatsu, Noriya Uedo, Yoshinobu Yamamoto, Hiromitsu Kanzaki, Shinichiro Hori, Kenshi Yao, Ichiro Oda, Satoshi Tanabe, Chizu Yokoi, Ken Ohata, Kenichi Yoshimura, Hideki Ishikawa & Manabu Muto.

Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial

J Gastroenterol. 2020 Dec;55(12):1127-1137.

Okano N, Morizane C, Nomura S, Takahashi H, Tsumura H, Satake H, Mizuno N, Tsuji K, Shioji K, Asagi A, Yasui K, Kitagawa S, Kashiwada T, Ishiguro A, Kanai M, Ueno M, Ogura T, Shimizu S, Tobimatsu K, Motoya M, Nakashima K, Ikeda M, Okusaka T, Furuse J.

Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).

Int J Clin Oncol. 2020 Oct;25(10):1835-1843.

Inagaki-Kawata Y, Yoshida K, Kawaguchi-Sakita N, Kawashima M, Nishimura T, Senda N, Shiozawa Y, Takeuchi Y, Inoue Y, Sato-Otsubo A, Fujii Y, Nannya Y, Suzuki E, Takada M, Tanaka H, Shiraishi Y, Chiba K, Kataoka Y, Torii M, Yoshibayashi H, Yamagami K, Okamura R, Moriguchi Y, Kato H, Tsuyuki S, Yamauchi A, Suwa H, Inamoto T, Miyano S, Ogawa S, Toi M.

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants.

Commun Biol. 2020 Oct 16;3(1):578.

Tomohiro Kondo, Junichi Matsubara, Pham Nguyen Quy, Keita Fukuyama, Motoo Nomura,Taro Funakoshi, Keitaro Doi, Yuichi Sakamori, Masahiro Yoshioka, Akira Yokoyama, Masashi Tamaoki, Tadayuki Kou, Kenshiro Hirohashi, Atsushi Yamada, Yoshihiro Yamamoto, Sachiko Minamiguchi, Masakazu Nishigaki, Takahiro Yamada, Masashi Kanai, Shigemi Matsumoto, Manabu Muto.

Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.

Cancer Sci. 2020 Oct 2;112(1):296-304.

Yoshinao Ozaki, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi, Shigeki Kataoka, Yoshitaka Nishikawa, Takahiro Horimatsu, Atsushi Yonezawa, Takeshi Matsubara, Motoko Yanagita, Manabu Muto, Norihiko Watanabe.

Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses

Cancer Chemother Pharmacol.2020 Nov;86(5):693-699.

Prasannna M Chandranouleeswaran, Manti Guha, Masataka Shimonosono, Kelly A. Whealan, Gordon Ruthel, Sarmistha Mukherjee, Michael V Gonzalez, James Garifallou, Clementina Amesaros, Ian A. Blair, Renata Pellegrino, Eishi Noguchi, Hakon Hakonarson, Joseph A. Baur, Noah Engel, Hisatsugu Maekawa, Uma M. Sachdeva, Shinya Ohashi, Andres Klein-Szanto, Hiroshi Nakagawa.

Autophagy migrates ethanol-induced mitochondrial dysfunction and oxidative stress in esophageal keratinocytes.

PLoS One. 2020 Sep 23;15(9):e0239625.

Chikatoshi Katada, Tetsuji Yokoyama, Tomonori Yano, Ichiro Oda, Yuichi Shimizu, Kenichi Takemura, Tomoyuki Koike, Kohei Takizawa, Motohiro Hirao, Hiroyuki Okada, Norisuke Nakayama, Yutaro Kubota, Yasumasa Matsuo, Hirofumi Kawakubo, Hideki Ishikawa, Akira Yokoyama, Manabu Muto.

Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions.

Dis Esophagus. 2020 Sep 4;33(9):doz110.